Advicenne (XPAR:ALDVI) Total Long-Term Assets : €1.51 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Advicenne Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Advicenne's Total Long-Term Assets for the quarter that ended in Jun. 2024 was €1.51 Mil.

Advicenne Total Long-Term Assets Historical Data

The historical data trend for Advicenne's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advicenne Total Long-Term Assets Chart

Advicenne Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Long-Term Assets

Get a 7-Day Free Trial

2.24

3.22

2.27

2.18

3.15

Advicenne Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Long-Term Assets	Get a 7-Day Free Trial													2.32	2.18	2.60	3.15	1.51

Advicenne Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Advicenne Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Advicenne's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Advicenne Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advicenne SA (XPAR:ALDVI) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

3MM:Germany

Address

2, rue Briconnet, Nimes, FRA, F-30 000

Website

http://www.advicenne.com

Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. Its goal is to improve the lives of patients from early childhood through adulthood.

Advicenne Headlines

No Headlines